Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IBD Cancer and Serious Infection in Europe

NCT02377258 is registered in ClinicalTrials.gov with Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives as lead sponsor.

NCT NCT02377258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02377258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IBD Cancer and Serious Infection in Europe
Lead sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Phase
Observational
Overall status
Completed
Start date
March 4, 2016
Completion date
May 16, 2022
Enrollment
13,262 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ibd